Search
Menu
Home
Sources
About
Contacts
PF-05089771
PF-05089771
is a
selective
,
small-molecule
Na
v
1.7 and Na
v
1.8
voltage-gated sodium channel
blocker
under development
by
Pfizer
as a
novel
analgesic
. As of
June 2014
, it has
completed
phase II
clinical trials
for
wisdom tooth removal
and
primary erythromelalgia
.